氟伐二醇

氟伐二醇

tert-Butyl (E)-3,5-dihydroxy-7-[3'-(4''-fluorophenyl)-1'-methylethyl-indol-2'-yl]-6-heptenoate

129332-29-2

C28H34FNO4

467.57

(E)-7-[3'-(4''-氟苯基)-1'-异丙基吲哚-2'-基]-3,5-二羟基-6-庚烯酸叔丁酯;氟伐二醇;氟伐他汀钠中间体 F4;3 F-4(E)-7-[3-(4-氟苯基)-1-异丙基吲哚-2-基]-3,5-二羟基-6-庚烯酸叔丁酯

T-BUTYL(E)-3,5-DIHYDROXY-7-[3'-(4''-FLUOROPHENYL)-1'-METHYLETHYL-INDOL-2'-YL]-6-HEPTENOATE;tert-Butyl (E)-3,5-dihydroxy-7-[3'-(4''-fluorophenyl)-1'-methylethyl-indol-2'-yl]-6-heptenoate;t-Butyl(E)-3,5-dihydroxy-7-[3'-(4''-fluorophenyl)-1'-methylethyl-indol-2'-yl]-6-;tert-Butyl (E)-3,5-d;(R*,S*-(E))-(±)-7-[3- (4-fluorophenyl)-1-(-1-Methylethyl)-1H-indol-2-yl]-3, 5-dihydroxy-6-heptenoic acid 1,1-diMethyl ester;Fluvastatin Related Compound B (15 mg) ([R*,S*-E]-(+/-)-7-[3-(4-fluorophenyl)-1-methylethyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid 1,1, dimethylethyl ester);(6E)-7-{3-[1-(4-fluorophenyl)propan-2-yl]-1H-indol-2-yl}-3,5-dihydroxy-8,8-diMethylnon-6-enoate;Fluvastatin sodiuM interMediate F4

-

-

-

-

-